To suppress tumor angiogenesis, various strategies have been utilized to inhibit BMP-9/10-ALK1 signaling, such as soluble form receptors, neutralizing antibodies, and small-molecule receptor inhibitors. The gene discussed is GDF2; the disease is neoplasm.